30 August 2021. A late-stage clinical trial has found that a three-dose new Chinese vaccine to be nearly 82% effective in preventing diseases related to COVID-19 and over 77% effective against the highly transmissible Delta variant of the novel coronavirus.https://covid-19.chinadaily.com.cn/a/202108/30/WS612c31b9a310efa1bd66bedd.html